Fig. 1From: Research progress on non-protein-targeted drugs for cancer therapyThe schematic diagram of antisense oligonucleotides clinically designed for tumor targets, such as Bcl-2, Grb2, CLU, Hsp27, STAT3, c-Raf, HIF-1α, AR, and XIAP (bold font)Back to article page